Acne Vulgaris: Pathogenesis, Treatment, and Needs Assessment

Page created by Joel Herrera
 
CONTINUE READING
A c n e Vu l g a r i s :
Pathogenesis,
Trea tment, and
N e e d s As s e s s m e n t
Siri Knutsen-Larson, MDa,1, Annelise L. Dawson, BAa,1,
Cory A. Dunnick, MDa,*,
Robert P. Dellavalle, MD, PhD, MSPHb

 KEYWORDS
  Acne vulgaris  Epidemiology  Treatment

Acne vulgaris is a common skin condition with              the absence of a universally accepted diagnostic
substantial cutaneous and psychologic disease              or grading schema. Additionally, estimates
burden. Studies suggest that the emotional impact          continue to change as the prevalence of acne
of acne is comparable to that experienced by               decreases secondary to improved treatment
patients with systemic diseases, like diabetes             modalities.9 Acne is most common in adolescents,
and epilepsy.1–3 In conjunction with the consider-         affecting approximately 85% of teenagers.9,10
able personal burden experienced by patients               Acne prevalence after adolescence decreases
with acne, acne vulgaris also accounts for                 with increasing age, but disease burden in younger
substantial societal and health care burden. Amer-         adults is still quite high.8 A common misconcep-
icans use more than 5 million physician visits for         tion by the medical and lay community is that
acne each year, leading to annual direct costs in          acne is a self-limited teenage disease and, thus,
excess of $2 billion.4,5 Acne is the most common           does not warrant attention as a chronic disease.
diagnosis made by dermatologists and is also               Nevertheless, the chronicity of many cases of
commonly made by nondermatologist physi-                   acne as well as the well-documented psychologic
cians.6,7 The pathogenesis and existing treatment          effects of chronic acne contributes to the burden
strategies for acne are complex.8 This article             of the disease.2,3,11
discusses the epidemiology, pathogenesis, and                 The average age of onset of acne is 11 years in
treatment of acne vulgaris. The burden of disease          girls and 12 years in boys.12,13 Acne is increasing
in the United States and future directions in the          in children of younger ages, with the appearance
management of acne is also addressed.                      of acne in patients as young as 8 or 9 years of
                                                           age. This trend toward earlier development of
                                                           acne is thought to be related to the decreasing
EPIDEMIOLOGY
                                                           age-of-onset of puberty that has been observed
Acne is a highly common skin condition. Still, esti-       in the United States.14 Acne is more common in
mates of acne prevalence vary substantially given          males in adolescence and early adulthood, which

 a
   Department of Dermatology, University of Colorado Denver, PO Box 6511, Mail Stop 8127, Aurora, CO 80045,
 USA
 b
   Dermatology Service, Denver Department of Veterans Affairs Medical Center, University of Colorado School
                                                                                                                 derm.theclinics.com

 of Medicine, Colorado School of Public Health, 1055 Clermont Street, Mail Code #165, Denver, CO 80220, USA
 1
   Both authors contributed equally to this article.
 * Corresponding author. Department of Dermatology, University of Colorado Denver School of Medicine,
 Aurora Court F703, PO Box 6510, Aurora, CO 80045.
 E-mail address: cory.dunnick@ucdenver.edu

 Dermatol Clin 30 (2012) 99–106
 doi:10.1016/j.det.2011.09.001
 0733-8635/12/$ – see front matter Ó 2012 Elsevier Inc. All rights reserved.
100        Knutsen-Larson et al

      is a trend that reverses with increasing age.12,13 It        hyperplasia, and various endocrine tumors, result
      is well known that adult acne is more common in              in a higher circulating level of androgens and
      women. Adult acne typically represents chronic               are associated with the development of acne
      acne persisting from adolescence, not new-onset              vulgaris.27
      disease.15,16                                                   The corporal distribution of acne depends on pi-
         Other factors impacting acne prevalence and               losebaceous gland density and morphology and,
      severity include ethnicity and genetic propensity.           thus, is common in regions where these structures
      Acne age of onset and disease character vary                 are largest and most abundant: the face, chest,
      among patients of different ethnicities. Scarring            neck, and back. Noninflammatory acne is charac-
      and pigmentary changes are common in skin of                 terized by the formation of open or closed
      color. Propensity to scar and to develop hyperpig-           comedones. Open comedones, or blackheads,
      mentation is highest among Hispanic and African              demonstrate darkly colored hyperkeratotic plugs
      American patients, respectively.12,17 These long-            within the follicular opening. This dark coloration
      term disease consequences are challenging to                 is related to the oxidation of melanin and not dirt,
      treat and contribute to the disease burden. In               as is a common public misconception. Closed
      addition, genetic factors impact the propensity              comedones, or whiteheads, are white to flesh
      to develop acne. Adolescent and adult acne is                toned in color and seem not to have a central
      more common in children of parents with a history            open pore.25
      of acne.12,18,19                                                Changes in the skin’s natural flora accompany
         Several modifiable factors alter acne risk. Ciga-         this androgen-related increase in sebum produc-
      rette smoking, for example, raises acne risk with            tion. Propionibacterium acnes, a normal compo-
      disease severity worsening in a dose-dependent               nent of the cutaneous flora, inhabits the
      fashion with increasing number of cigarettes                 pilosebaceous unit using lipid-rich sebum as
      smoked daily.13 Although evidence regarding the              a nutrient source. P acnes, therefore, flourishes
      impact of dietary factors on acne is equivocal,              in the presence of increased sebum production,
      studies suggest that dairy intake increases acne             leading to inflammation via complement activa-
      risk.20–22 Finally, traditional opinion in dermatology       tion and the release of metabolic byproducts,
      holds that acne tends to improve during summer               proteases, and neutrophil-attracting chemotactic
      months when sun exposure is greater. 23 This                 factors.25,28 Inflammatory acne vulgaris lesions,
      finding is supported by an observed seasonal                 such as papules, pustules, nodules, or cysts,
      decrease in physician visits for acne during                 develop when comedones rupture and contents
      summer months.24 Nevertheless, no studies exist              of the pilosebaceous unit spill into the surrounding
      to support this association and use of UV light to           dermis.25,29 In severe cases, adjacent cysts may
      treat acne has been rejected.23 Undoubtedly,                 coalesce to form channels or draining sinuses.
      acne is a complex disease process influenced by              Inflammatory acne may produce cutaneous scar-
      both genetic and environmental factors.                      ring or hyperpigmentation that persists long after
                                                                   acne resolution.25
      PATHOGENESIS
                                                                   PREVENTION
      The pathogenesis of acne is a result of multifac-
      eted processes within the pilosebaceous unit re-             External factors play an important role in the devel-
      sulting in bacterial overgrowth and inflammation.            opment of acne lesions. Cigarette smoking and
      This condition typically develops at the time of             dietary factors increase acne risk and disease
      the pubertal transition when changes in the body’s           severity. In addition, certain skin and hair products
      hormonal milieu alter pilosebaceous gland func-              and use of occlusive clothing articles contribute to
      tion. Initially, follicular epithelial cells differentiate   acne development. The removal of any of these
      abnormally and form tighter intracellular adhesions          factors may lead to an improvement in disease
      and, therefore, are shed less readily. This process          severity.
      leads to the development of hyperkeratotic plugs,               The link between smoking and acne is well es-
      or microcomedones, which enlarge progressively               tablished.13 Even though smoking avoidance and
      to form noninflammatory, closed or open come-                cessation should be encouraged in all patients,
      dones. 25 Circulating and cutaneously derived                this preventive message is especially important
      androgens, often named the primary inciting factor           for patients suffering from acne. Practitioners
      in the development of acne, induce sebum                     should emphasize not only that smoking increases
      production, further contributing to the develop-             acne risk but also that a dose-dependent relation-
      ment of comedones.26 Conditions, such as poly-               ship exists between daily cigarette use and acne
      cystic ovarian syndrome, congenital adrenal                  disease severity.
Acne Needs Assessment               101

  The controversial relationship between diet and           A primary initial treatment approach is proper
acne has been studied for many years. There is no        skin care. This care includes eliminating the afore-
reputable evidence to support a link between acne        mentioned extrinsic factors as well as encouraging
and chocolate. Recently, however, studies have           proper skin hygiene and adherence to prescribed
suggested an association between milk and                acne treatment regimens. Although it was previ-
acne.20–22 This finding is based on increased            ously thought that excessive skin cleansing
levels of insulinlike growth factor 1 in milk causing    contributes to the formation of acne, several small
an increase in circulating androgens. Associations       studies indicate that facial cleansing, even when
of omega-3 fatty acids, antioxidants, zinc, vitamin      performed up to 4 times daily, is not harmful and
A, and iodine with acne have also been proposed.         may, in fact, diminish acne severity.38–40 Patient
However, all of these areas require further              education in proper hygiene includes counseling
research.30 Dietary modification alone is not            regarding appropriate skin cleanser and moistur-
adequate for acne prevention regardless of the           izer selection.41
association between diet and acne. Individuals              If skin care alone does not lead to the resolution
with acne wishing to make dietary changes should         of cutaneous lesions, topical and systemic antimi-
focus on the avoidance of dairy products as              crobials may be used. Topical antibiotics may be
perhaps the most evidence-based intervention.            used to treat mild to moderate acne. Systemic
  Facial and hair products, especially cosmetics         antibiotics are indicated when acne is moderate
and hair products containing oils, may lead to an        to severe or if disease manifestations are
exacerbation of acne lesions.17,31 In addition,          producing marked psychosocial stress for
repeated scrubbing with soaps, detergents, and           patients.28 The purpose of this treatment modality
other agents can cause trauma to underlying              is to decrease the presence of P acnes on the skin
comedones, thereby increasing inflammation.              surface and within the pilosebaceous unit.42 Anti-
Thus, individuals with acne should select oil-free       biotics confer more than antimicrobial properties.
or noncomedogenic products and refrain from              They also produce antiinflammatory effects, inhibit
aggressively rubbing the face.32 Other factors           neutrophil chemotaxis, and alter compliment path-
also contribute to pore occlusion, including tight       ways, all of which aid in the treatment of acne.28
clothing and head gear. Hence, these articles            Various classes of antibiotics, such as sulfon-
should be avoided when possible.                         amides, macrolides, tetracyclines, and dapsone,
                                                         may be used to treat acne.28,42
TREATMENT                                                   Widespread and long-term use of antibiotics
                                                         has led to the development of P acnes resistance
In the United States, there is an overabundance          and has also been associated with Staphylo-
of treatment recommendations for patients with           coccus resistance.28,43,44 Thus, when treating
acne. Unfortunately, few of these recommenda-            with antimicrobials, the prescribing clinician must
tions are evidenced based and comparative                consider not only local patterns of resistance but
studies are limited.33 In fact, in 2009, the Institute   also patient adherence to a regimen that will not
of Medicine listed acne as a priority for comparative    promote selection for resistant bacterial strains.
effectiveness research evaluating treatment regi-        It is also important to avoid protracted antibiotic
mens.34 Recently published treatment algorithms          courses. Monotherapy with antimicrobials should
include A Global Alliance to Improve Outcomes            be avoided, especially when using macrolides
in Acne, those endorsed by the American                  that are most often associated with the develop-
Academy of Dermatology, and recommendations              ment of resistance.28,44 Instead, successful treat-
from a European expert group on oral antibiotics         ment is often seen when pairing antimicrobials
to treat acne.32,35,36 These recommendations are         with benzoyl peroxide, hormonal therapies, and
based on expert opinion given the limited evidence       retinoid preparations.28,42
available. All of the guidelines recommend similar          In women with mild to moderate acne,
approaches focusing on acne severity and degree          combined oral contraceptives (COCs) can be
of inflammation. In addition, acne treatment recom-      used. A recent Cochrane review concluded that
mendations may be based on skin type, clinical           this method of treatment reduces acne severity
classification of acne, and preexisting acne             when compared with placebo.45 Even though
scaring.37 Treatment options include proper skin         androgen levels are often normal in women with
care, topical and oral antimicrobials, topical and       acne vulgaris, hormonal therapies combating
systemic retinoids, benzoyl peroxide, and oral           androgens seem to benefit these patients.46
contraceptives for female patients. These treat-         Progestins tend to be proandrogenic but most
ments are often used in combination to achieve           COCs are estrogen dominant. Estrogen containing
disease resolution.                                      oral contraceptives increase circulating levels of
102        Knutsen-Larson et al

      steroid hormone binding globulin which results in        common atrophic scars and hypertrophic scars.
      lower circulating levels of testosterone. Different      Treatments for acne scarring include, but are not
      COCs contain varying levels of progestins and            limited to, topical treatments, chemical peels,
      the implications of this require further research.45     dermabrasion, laser, and dermal grafting. Unfortu-
      In women with mild to moderate acne who do               nately, there are no well-accepted guidelines to
      not desire childbearing, COCs are a good treat-          optimize acne scar treatment. Additional research
      ment recommendation. Oral contraceptives are             is required to determine cost-effectiveness and
      often paired with other acne therapies.32                establish the duration of treatment effects.52
         Topical retinoids represent the most commonly
      prescribed treatment option because they are             BURDEN OF TREATMENT
      effective in both the treatment and prevention of
      acne.47 The mechanism of action of retinoids             The annual cost of acne treatment is quite high
      involves preventing the primary acne lesion, which       given the prevalence and chronicity of the
      decreases inflammation.48 This drug class is an          disease. Acne represents the most common
      excellent choice for both initial and maintenance        dermatologic diagnosis in the United States.6,7
      therapy and assists many patients in achieving           A study based on data from 2004 estimates that
      adequate disease control. Depending on the               the annual direct cost of acne management is
      case, topical retinoids can be paired with               more than $2.5 billion. Acne ranks second only
      benzoyl peroxide, antimicrobials, or with oral           to skin ulcers and wounds in annual cost burden
      contraceptives.                                          for dermatologic illness.4
         Finally, oral isotretinoin is an option for severe,      In addition to the high cost burden, the treat-
      refractory acne. The mechanism of action includes        ment of acne produces heavy physician demands.
      decreasing sebaceous gland activity with a resul-        Acne accounts for more than 5 million physician
      tant decrease in sebum secretion. This action            visits annually, or approximately 8% of all derma-
      effectively diminishes overgrowth of P acnes,            tologic health care visits.5,7,53 Two-thirds of physi-
      which is a key pathogenic factor. The drug also          cian visits for acne are made by women,
      inhibits keratinocyte hyperplasia and instead            suggesting that women are more likely than men
      promotes normal differentiation.49 Isotretinoin          to seek medical care for acne.53,54 Contrary to
      must be prescribed carefully because it carries          the perception of acne as a disease of adolescents
      several black box warnings, including teratoge-          only, individuals aged older than 18 years account
      nicity, possible change in mood status, and hyper-       for more than 60% of acne-related visits. Never-
      triglyceridemia, among others.49,50 This drug is the     theless, the health care burden of adolescent
      only acne treatment option that permanently              acne is substantial, with patients aged 12 to 17
      changes the course of the disorder. However,             years composing nearly 40% of the visits.
      because of the considerable side effects, it should      Although recent studies have demonstrated an
      only be used in those with refractory nodular acne.      increase in acne prevalence for children aged
         Given the increasing trend toward treatment           younger than 12 years, these patients account
      with several agents simultaneously, providers            for the minority of health care visits or less than
      have come to rely on the use of combination              2% of all physician visits for acne.54
      agents in the treatment of acne. These agents
      include pairings of topical antibiotics with benzoyl     AVAILABLE SERVICES
      peroxide, topical antibiotics with retinoids, and
      others. Use of combined agents has been demon-           Acne vulgaris is managed in the outpatient setting
      strated to improve patient adherence to                  by both specialist and generalist physicians.
      prescribed regimens.51 Given that poor adherence         Dermatologists provide approximately two-thirds
      to complex medication regimens limits treatment          of all acne care in the United States, followed by
      efficacy and contributes to the chronicity and           pediatricians (16%), general/family practitioners
      burden of acne, providers should aim to simplify         (12%), internists (5%), and obstetricians/gynecol-
      treatment regimens and use combined agents               ogists (1%).55 Long wait times and poor geo-
      when feasible.                                           graphic distribution of the dermatologic workforce
                                                               are 2 factors thought to promote the use of non-
      ACNE SCARRING                                            dermatologist care in acne treatment.56,57 Further-
                                                               more, several characteristics, including being
      Despite the many treatment options, acne scars           younger than 18 years of age, Hispanic ethnicity,
      still develop in some patients. They result from         receipt of care in the West or Midwest, and the
      skin damage during the healing process of acne.          use of public medical insurance, are predictive of
      Acne scars are divided into 2 groups: more               nondermatologist acne care.55
Acne Needs Assessment              103

   Use of nondermatologist care in acne treatment         dermatologists in their geographic region. Acne-
is relevant because it may not be equivalent to the       Net (http://skincarephysicians.com/acnenet/
care provided by dermatologists. Studies report           index.html) provides similar patient material on-
differences in prescribing patterns and varying           line. Social networking and other online media
regimen complexity between dermatologists and             sources host abundant content describing acne
general practitioners. In particular, generalists are     management. Although much of this online
less likely to prescribe topical retinoids and are        content is unregulated and should be interpreted
more likely to prescribe antibiotic monotherapy,          carefully, numerous reliable health information
which are trends not in line with the present             sources exist. Physicians should be aware of
recommendations.47,58                                     the many accurate online resources to which
   Overall, generalists receive limited training in the   they can direct patients as well as the unregulated
treatment of dermatologic disease. US medical             content their patients may be accessing.
schools provide on average only 21 hours of
dermatology training before graduation, and               FUTURE DIRECTIONS
dermatologic training in pediatric and internal
medicine residencies is limited.59–61 Dermatolo-          Going forward, several priorities should guide
gists diagnose acne many times more frequently            acne research and management efforts. First, it
then do their generalist counterparts and this            is imperative that comparative effectiveness
quantity of experience also contributes to the            research is emphasized and evidence-based
expertise of dermatologists in treating acne.7,62         treatment strategies are established for acne.
Even so, the role of nondermatologist care of             Not only will this enhance patient outcomes but
acne should not be undervalued, given the                 this will also allow for better control of the costs
substantial burden of acne. Medical school and            and physician demands associated with acne
residency training programs should place greater          treatment. The establishment of optimal treatment
emphasis on dermatologic education. Future                regimens would be expected to diminish the chro-
efforts to develop standardized, evidence-based           nicity and, hence, burden of acne disease.
acne treatment guidelines may assist nonderma-            Furthermore, standardized recommendations
tologists in providing comparable acne care.              would help enable nondermatologist physicians
   In addition to the acne treatment by physicians,       to provide appropriate care and assist in meeting
there has also been a growing trend toward the            the demands of acne management. Likewise,
use of physician assistants (PAs) and other midle-        medical school and residency training programs
vel providers in the management of dermatologic           must emphasize dermatology education. General-
disease. In fact, dermatologists are second only          ists commonly manage dermatologic illness and
to ophthalmologists in their use of PAs. In 1997,         their ability to effectively do so relies heavily on
1 in every 32 patients visiting a dermatology clinic      adequate training.
was seen by a PA, which is a proportion that is              Efforts to explore alternative care resources
thought to have increased markedly since that             should be supported. Already, the use of PAs
time. PAs work under the supervision of a physi-          and other midlevel providers has been established
cian; however, more than one-quarter of patients          in dermatologic practice. Further analyses of the
seeing a PA for dermatologic complaints are not           efficacy and cost-effectiveness of midlevel
directly evaluated by a physician.63 To the authors’      provider care should be pursued. Additionally, in
knowledge, no exact figures are available for the         recent years, the use of the teledermatology and
use of PAs in the treatment of acne specifically.         Internet-based dermatologic care in the treatment
Nevertheless, anecdotal experience indicates              of acne has been explored. The use of digital
that acne is a condition commonly managed by              images to monitor treatment progress has been
dermatology PAs and that the use of PAs to eval-          proposed and may be reliable with certain assess-
uate acne may diminish the costs associated with          ment measures, such as total inflammatory lesion
acne management. Further analyses of the effi-            count.64 Similarly, online follow-up visits for acne
cacy and cost of PA management of acne are                have been demonstrated to produce equivalent
warranted.                                                patient outcomes.65 The use of digital and online
   In addition to the care resources offered              resources to treat acne may diminish cost burden
through physicians and midlevel providers, many           and assist in making dermatology services avail-
online resources are available to patients suffering      able to patients in regions with limited dermato-
from acne. The American Academy of Derma-                 logic resources.
tology (www.aad.org) offers detailed patient infor-          Finally, cellular phone and Internet technology
mation on acne and also hosts a searchable                may be used to promote adherence to treatment
database that aids patients in locating                   regimens through the use of patient reminders.
104        Knutsen-Larson et al

                                                                       dermatologists: is decreasing the number of derma-
       List of Acronyms
                                                                       tologists the appropriate response? Dermatol Online
       COCS               Combined oral contraceptives                 J 1998;4(1):3.
                                                                  7.   Stern RS. Dermatologists and office-based care of
       IGF-I              Insulin like growth factor I
                                                                       dermatologic care in the 21st century. J Investig
       P Acnes            Propionibacterium Acnes
                                                                       Dermatol Symp Proc 2004;9(2):126–30.
                                                                  8.   Collier C, Harper J, Cantree W, et al. The prevalence
                                                                       of acne in adults 20 years and older. J Am Acad
      Adolescents and young adults, the patients most                  Dermatol 2007. Available at: http://www.eblue.org.
      impacted by acne, are simultaneously highly                      Accessed January 10, 2011.
      receptive to the use of technology and prone to             9.   Stathakis V, Kilkenny M, Marks R. Descriptive epide-
      medication noncompliance. Improved treatment                     miology of acne vulgaris in the community. Australas
      adherence could help to diminish the acne                        J Dermatol 1997;38:115–23.
      burden of disease. Physicians must proceed                 10.   Kraning K, Odland G. Prevalence, morbidity and
      creatively yet cautiously as they develop new                    cost of dermatologic diseases. J Invest Dermatol
      approaches to manage acne and control disease                    1979;73:395–401.
      burden.                                                    11.   Gollnick HPM, Finlay AY, Shear N. Can we define
                                                                       acne as a chronic disease? Am J Clin Dermatol
                                                                       2008;9(5):279–84.
      SUMMARY
                                                                 12.   Dreno B, Poli F. Epidemiology of acne. Dermatology
      Acne vulgaris is a common dermatologic disease                   2003;206:7–10.
      that results in high monetary and physician use            13.   Schafer T, Nienhaus A, Vieluf D, et al. Epidemiology
      demands in the United States. The pathogenesis                   of acne in the general population: the risk of
      and treatment of acne is complex and requires                    smoking. Br J Dermatol 2001;145:100–4.
      ongoing research to establish best-practice guide-         14.   Friedlander SF, Eichenfield LF, Fowler JF, et al. Acne
      lines. In the meantime, physicians should empha-                 epidemiology and pathophysiology. Semin Cutan
      size existing evidence-based recommendations,                    Med Surg 2010;29:2–4.
      including the use of topical retinoids and avoid-          15.   Goulden V, Clark S, Cunliffe W. Post adolescent
      ance of antibiotic monotherapy, in the treatment                 acne: a review of clinical features. Br J Dermatol
      of acne. Moreover, clinicians must continue to                   1997;136:66–70.
      pursue innovative strategies, such as the use of           16.   Goulden V, Stables I, Cunliffe WJ. Prevalence of
      nonphysician providers, teledermatology, and                     facial acne in adults. J Am Acad Dermatol 1999;
      other technologic resources, as a means by which                 41(4):577–80.
      to enhance acne management and limit the                   17.   Taylor SC, Cook-Bolden F, Rahman Z, et al. Acne
      substantial burden of this prevalent disease.                    vulgaris in skin of color. J Am Acad Dermatol
                                                                       2002;46(Suppl 2):S98–106.
      REFERENCES                                                 18.   Ghodsi SZ, Orawa H, Zouboulis CC. Prevalence,
                                                                       severity, and severity risk factors of acne in high
       1. Mallon E, Newton J, Klassen A, et al. The quality of         school pupils: a community-based study. J Invest
          life in acne: a comparison with general medical              Dermatol 2009;129:2136–41.
          conditions using generic questionnaires. Br J Der-     19.   Goulden V, McGeown CH, Cunliffe WJ. The familial
          matol 1999;140:672–6.                                        risk of adult acne: a comparison between first-
       2. Dalgard F, Gieler U, Holm JO, et al. Self-esteem and         degree relatives of affected and unaffected individ-
          body satisfaction among late adolescents with acne:          uals. Br J Dermatol 1999;141:297–300.
          results from a population survey. J Am Acad Derma-     20.   Davidovici BB, Wolf R. The role of diet in acne: facts
          tol 2008;59:746–51.                                          and controversies. Clin Dermatol 2010;28:12–6.
       3. Uhlenhake E, Yentzer BA, Feldman SR. Acne vulga-       21.   Spencer EH, Ferdowsian HR, Barnard ND. Diet and
          ris and depression: a retrospective examination.             acne: a review of the evidence. Int J Dermatol 2009;
          J Cosmet Dermatol 2010;9:59–63.                              48:339–47.
       4. Bickers DR, Lim HW, Margolis D, et al. The burden of   22.   Adebamowo C, Spiegelman D, Berkey CS, et al.
          skin diseases: 2004. J Am Acad Dermatol 2006;                Milk consumption and acne in teenaged boys.
          55(3):490–500.                                               J Am Acad Dermatol 2008;58:787–93.
       5. Fleischer AB Jr, Feldman SR, Rapp SR. Introduction.    23.   Gfesser K, Worret WI. Seasonal variations in the
          The magnitude of skin disease in the United States.          severity of acne vulgaris. Int J Dermatol 1996;35:
          Dermatol Clin 2000;18(2):xv–xxi.                             116–7.
       6. Thompson TT, Feldman SR, Fleischer AB. Only 33% of     24.   Hancox JG, Sheridan SC, Feldman SR, et al.
          visits for skin disease in the US in 1995 were to            Seasonal variation of dermatologic disease in the
Acne Needs Assessment                  105

      USA: a study of office visits from 1990 to 1998. Int J   43. Eady EA. Bacterial resistance in acne. Dermatology
      Dermatol 2004;43:6–11.                                       1998;196(1):59–66.
25.   Brown SK, Shalita A. Acne vulgaris. Lancet 1998;         44. Eady EA, Gloor M, Leyden JJ. Propionibacterium
      351(9119):1871–6.                                            acnes resistance: a world wide problem. Derma-
26.   Chen W, Thibouot D, Zouboulis CC. Cutaneous                  tology 2003;206(1):54–6.
      androgen metabolism: basic research and clinical         45. Arowojolu A, Gallo M, Lopez L, et al. Combined oral
      perspectives. J Invest Dermatol 2002;119(5):                 contraceptive pills for the treatment of acne.
      992–1007.                                                    Cochrane Database Syst Rev 2009. Available at:
27.   Imperato-McGinley J, Gautier T, Cai L, et al. The            http://www.ncbi.nlm.nih.gov/pubmed/17253506.
      androgen control of sebum production. Studies of             Accessed January 15, 2011.
      subjects with dihydrotestosterone deficiency and         46. Bolognia J, Jorizzo J, Rapini R. Dermatology, vol 1.
      complete androgen insensitivity. J Clin Endocrinol           2nd edition. Philadelphia: Elsevier; 2003.
      Metab 1993;76:524–8.                                     47. Yentzer BA, Irby CE, Fleischer AB, et al. Differences
28.   Tan AW, Tan HH. Acne vulgaris: a review of antibiotic        in acne treatment prescribing patterns of pediatri-
      therapy. Expert Opin Pharmacother 2005;6(3):                 cians and dermatologists: an analysis of nationally
      409–18.                                                      representative data. Pediatr Dermatol 2008;25(6):
29.   Rubin E. Essential pathology. 3 edition. Baltimore           635–9.
      (MD): Lippincott Williams & Wilkins; 2001.               48. James W. Acne. N Engl J Med 2005;352(14):
30.   Bowe W, Joshi S, Shalita A. Diet and acne. J Am              1463–72.
      Acad Dermatol 2010;61(1):124–41.                         49. Ward A, Brogden R, Heel R, et al. Isotretinoin. A
31.   Nguyen Q, Kim Y, Schwartz R. Management of                   review of its pharmacological properties and thera-
      acne vulgaris. Am Fam Physician 1994;50(1):89–99.            peutic efficacy in acne and other skin disorders.
32.   Gollnick H, Cunliffe W, Benson D, et al. Management          Drugs 1984;28(1):6–37.
      of acne: a report from a global alliance to improve      50. Brelsford M, Beute T. Preventing and managing the
      outcomes in acne. J Am Acad Dermatol 2003;49:                side effects of isotretinoin. Semin Cutan Med Surg
      S1–37.                                                       2008;197(3):197–206.
33.   Williams HC, Dellavalle RP, Garner S. Acne vulgaris.     51. Yentzer BA, Ade RA, Fountain JM, et al. Simplifying
      Lancet 2011. [Epub ahead of print].                          regimens promotes greater adherence and
34.   Ratner R, Eden J, Wolman D, et al. Initial national          outcomes with topical acne medications: a random-
      priorities for comparative effectiveness research.           ized controlled trial. Cutis 2010;86:103–8.
      Institute of Medicine. Washington, DC: National          52. Fabbrocini G, Annunziata M, D’arco V, et al. Acne
      Academies Pr; 2009.                                          scars: pathogenesis, classification and treatment.
35.   Strauss J, Krowchuk DP, Leyden J. Guidelines of              Dermatol Res Pract 2010;2010:893080.
      care for acne vulgaris management. J Am Acad Der-        53. Stern RS. Medication and medical service utilization
      matol 2007;6(4):651–63.                                      for acne 1995-1998. J Am Acad Dermatol 2000;43:
36.   Dreno B, Bettoli V, Oschendorf F, et al. European            1042–8.
      expert group on oral antibiotics in acne. European       54. Yentzer BA, Hick J, Reese EL, et al. Acne vulgaris in
      recommendations on the use of oral antibiotics for           the United States: a descriptive epidemiology. Cutis
      acne. Eur J Dermatol 2004;14:391–9.                          2010;86:94–9.
37.   Haider A, Shaw J. Treatment of acne vulgaris. JAMA       55. Armstrong AW, Idriss N, Bergman H. Physician
      2004;292(6):726–35.                                          workforce for acne care in the United States, 2003
38.   Choi JM, Lew VK, Kimball AB. A single-blinded,               through 2005. Arch Dermatol 2009;145(10):1195–6.
      randomized, controlled clinical trial evaluating the     56. Resneck J Jr. Too few or too many dermatologists?
      effect of face washing on acne vulgaris. Pediatr Der-        Difficulties in assessing optimal workforce size.
      matol 2006;23(5):421–7.                                      Arch Dermatol 2001;137(10):1295–301.
39.   Draelos ZD. The effect of daily facial cleanser for      57. Tsang MW, Resneck JS Jr. Even patients with changing
      normal to oily skin on the skin barrier of subjects          moles face long dermatology appointment wait-times:
      with acne. Cutis 2006;78(Suppl 1):34–40.                     a study of stimulated patient calls to dermatologists.
40.   Choi YS, Suh HS, Yoon MY, et al. A study of the effi-        J Am Acad Dermatol 2006;55(1):54–8.
      cacy of cleansers for acne vulgaris. J Dermatolog        58. Balkrishnan R, Fleischer AB Jr, Paruthi S, et al.
      Treat 2010;21:201–5.                                         Physicians underutilize topical retinoids in the
41.   Goodman G. Cleansing and moisturizing in acne                management of acne vulgaris: analysis of U.S.
      patients. Am J Clin Dermatol 2009;10:S1–6.                   national practice data. J Dermatolog Treat 2003;
42.   Leyden J, Rosso JD, Webster G. Clinical consider-            14:172–6.
      ations in the treatment of acne vulgaris and other       59. McCarthy GM, Lamb GC, Russell TJ, et al. Primary
      inflammatory skin disorders: a status report. Derma-         care-based dermatology practice: internists need
      tol Clin 2009;27:1–15.                                       more training. J Gen Intern Med 1991;6:52–6.
106        Knutsen-Larson et al

      60. Ramsay DL, Weary PE. Primary care in dermatology:           of dermatologic health care. Dermatol Clin 2000;
          whose role should it be? J Am Acad Dermatol 1996;           18(2):297–302.
          35:1005–8.                                              64. Bergman H, Tsai KY, Seo SJ, et al. Remote assess-
      61. Prose NS. Dermatology training during the pediatric         ment of acne: the use of acne grading tools to eval-
          residency. Clin Pediatr 1988;27:100–3.                      uate digital skin images. Telemed J E Health 2009;
      62. Fleischer AB, Herbert CR, Feldman SR. Diagnosis of          15(5):426–30.
          skin disease by non-dermatologists. Am J Manag          65. Watson AJ, Bergman H, Williams CM. A randomized
          Care 2000;6:1149–56.                                        trial to evaluate the efficacy of online follow-up visits
      63. Clark AR, Monroe JR, Feldman SR, et al. The                 in the management of acne. Arch Dermatol 2010;
          emerging role of physician assistants in the delivery       146(4):406–11.
You can also read